Home Drug Codes J Codes J9370 · VINCRISTINE SULFATE
Updated July 1st, 2026

VINCRISTINE SULFATE J Code: J9370

Vincristine sulfate, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9370, effective October 1, 2026: $9.426 per HCPCS billing unit, down 1.1% from $9.529. From CMS's final file.

?
Medicare Payment Limit ?
$9.529
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
6
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Vincristine sulfate, 1 mg
HCPCS Added Date January 1, 1986
Manufacturer Hospira
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution | Not Available

About VINCRISTINE SULFATE

Vincristine Sulfate is a medication aligned to the HCPCS J Code: J9370 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Hospira.

According to CMS Drug Use Information: Vincristine is used to treat various types of cancer. It is a cancer chemotherapy drug that is usually used with other chemotherapy drugs to slow or stop cancer cell growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 6 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00703-4402-11 Vincristine Sulfate Teva Parenteral Medicines, Inc. 1 1 MG
00703-4412-11 Vincristine Sulfate Teva Parenteral Medicines, Inc. 2 1 MG
61703-0309-06 VinCRIStine Sulfate Hospira, Inc. 1 1 MG / 1 ML
61703-0309-16 VinCRIStine Sulfate Hospira, Inc. 2 2 MG / 2 ML
61703-0309-25 VinCRIStine Sulfate Hospira, Inc. 2 2 MG / 2 ML
•••••-••••-•• Log in to view VINCRISTINE SULFATE
Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

VINCRISTINE SULFATE Pricing & Reimbursement

J9370 Private Payer Reimbursement
$8.46 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

VINCRISTINE SULFATE Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 9.6%
Avg. Days to File 11.6days
Avg. Days to Pay 25.1days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9370 claims analytics on FocalPoint →
OnPoint Oncology

VINCRISTINE SULFATE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96409 Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Login for More Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More
JW / JZ modifiers apply

CMS has identified Vincristine Sulfate (J9370) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

VINCRISTINE SULFATE Medically Unlikely Edits (MUE)

The most billing units of J9370 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
4 units / day
= 4 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

VINCRISTINE SULFATE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute Leukemia Acute leukemia Hodgkin's Disease Hodgkin's disease Neuroblastoma Non-Hodgkin's Malignant Lymphomas Non-Hodgkin's malignant lymphomas Rhabdomyosarcoma Wilms' Tumor Wilms' tumor
Drug Class
Vinca Alkaloid [EPC]Vinca Alkaloids [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Vincristine Sulfate billing and coding guide?
We have not yet identified a manufacturer source of Vincristine Sulfate billing and coding information.
Are there any available Vincristine Sulfate patient assistance programs?
Our team did not identify a source for Vincristine Sulfate patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Vincristine Sulfate prescribing information?
Our team is still working to identify a prescribing information source for VINCRISTINE SULFATE
Where can I find Vincristine Sulfate side effect information?
Our team has not yet identified a source of side effects information for VINCRISTINE SULFATE. Please check back in a few weeks.
Does billing VINCRISTINE SULFATE require JZ/JW wastage modifiers?
CMS has identified VINCRISTINE SULFATE(J9370) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.